Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Med Food ; 22(4): 355-364, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30990752

RESUMEN

Our study aimed to investigate the effects of the polysaccharide-rich extract of Phragmites rhizoma (PEP) against water immersion restraint (WIR) stress and forced swimming-induced fatigue. Exposure to WIR stress significantly increased the ulcer index, bleeding score, the weight of the adrenal gland, blood glucose concentrations, total cholesterol, cortisol, and creatine kinase (CK). The weight of the spleen decreased significantly. In addition, myeloperoxidase (MPO) and thiobarbituric acid-reactive substance (TBARS) were significantly upregulated by WIR stress. The antioxidative factors such as glutathione (GSH) and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) in the stomach were decreased by WIR stress. Alterations induced by WIR stress were effectively reversed by pretreatment with PEP. The swimming endurance capacity of mice was significantly prolonged by the oral administration of PEP. Swimming-induced fatigue significantly reduced the body weight; however, the injection of PEP inhibited the decrease of body weight. The PEP-treated group had significantly lower CK levels in plasma, an indicator of muscle damage. These results indicated that PEP has anti-stress and anti-fatigue effects, which are mediated by suppressing the hyperactivation of the hypothalamus-pituitary-adrenal axis, and antagonism of the oxidative damages induced by WIR stress and prolonged swimming times.


Asunto(s)
Fatiga/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Poaceae/química , Polisacáridos/administración & dosificación , Animales , Catalasa/metabolismo , Modelos Animales de Enfermedad , Fatiga/metabolismo , Fatiga/fisiopatología , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Peroxidasa/metabolismo , Extractos Vegetales/química , Polisacáridos/química , Rizoma/química , Estrés Fisiológico/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Natación
2.
Arch Pharm Res ; 40(7): 854-863, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28643288

RESUMEN

Proteinase activated receptor 2 (PAR2), which is localized in the GI tract, the respiratory system, and the kidney tubules is a G protein-coupled receptor associated with inflammation, metabolism, and disease. The aim of this study was to explore the role of PAR2 in hydrogen peroxide (H2O2)-induced HepG2 cells by using FSLLRY-NH2 a PAR2 antagonist. H2O2 treatment resulted in induction of PAR2 in esophageal, gastric, and liver cells, with the most robust response being in HepG2 cells. Furthermore, this effect was dose-dependent in HepG2 cells. Treatment with H2O2 at concentrations above 400 µM for 24 h also reduced HepG2 cell viability. H2O2 treatment increased both the protein and mRNA levels of IL-1ß, IL-8, and TNF-α, as well as those of SAPK/JNK. The increased levels of these pro-inflammatory genes and SAPK/JNK induced by H2O2 were attenuated in a dose-dependent manner when cells were co-treated with H2O2 and FSLLRY-NH2. In summary, the PAR2 antagonist peptide, FSLLRY-NH2, reduces the level of the pro-inflammatory genes IL-8, IL-1ß, and TNF-α induced by H2O2, through the SAPK/JNK pathways in HepG2 cells. These data suggest that a PAR2 antagonist could be an anti-inflammatory agent in HepG2 cells.


Asunto(s)
Antiinflamatorios/farmacología , Inflamación/prevención & control , Oligopéptidos/farmacología , Receptor PAR-2/antagonistas & inhibidores , Animales , Antiinflamatorios/administración & dosificación , Gatos , Relación Dosis-Respuesta a Droga , Esófago/citología , Esófago/efectos de los fármacos , Esófago/patología , Femenino , Células Hep G2 , Humanos , Peróxido de Hidrógeno/administración & dosificación , Mediadores de Inflamación/metabolismo , Hígado/citología , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Oligopéptidos/administración & dosificación , ARN Mensajero/metabolismo , Receptor PAR-2/metabolismo , Estómago/citología , Estómago/efectos de los fármacos , Estómago/patología
3.
Korean J Physiol Pharmacol ; 17(5): 411-5, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24227941

RESUMEN

In this study, we investigated the protective action of glucuronopyranoside flavonoids (QGC, AGC, LGC) on gastritis in rats. QGC, AGC and omeprazole decreased the gastric volume significantly, and each ID50 was 0.75, 0.54 and 8.5 mg/kg, respectively, thus the order of potency was AGC, QGC and omeprazole. They also decreased acid output, and each ID50 was 7.81, 0.58 and 6.71 mg/kg, respectively, thus the order of potency was AGC, omeprazole and QGC. They inhibited gastritis induced by indomethacin, and it recovered significantly by increasing the GSH levels in gastritis. The gastric MPO activity in the gastritis group increased more than in the normal group. QGC, LGC, or AGC administration reduced moderately the MPO activity in a dose-dependent manner. This study demonstrated that AGC, QGC, or LGC showed potent efficacy on the gastritis, by preventing oxidative stress. These results suggest that QGC, AGC, or LGC have gastroprotective effect in rats.

4.
Korean J Physiol Pharmacol ; 16(1): 49-57, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22416220

RESUMEN

It has been shown that QGC isolated and purified from Rumecis folium found protective effects of gastritis and esophagitis which EXT is an ethanol extract of it. We examined acute toxicity and the general pharmacological action of QGC EXT to search for any side effects of it in rats, mice, guinea pigs, and cats. In a single dose toxicity study, QGC EXT didn't show toxicological effects in rats and mice, and the LD(50) was over 5 g/kg in both animals, and there were also no changes in weight, feed and water intake during these toxicological experimental periods. We examined the general pharmacological action on central controlled behavior responses, and peripheral organs including blood pressure, heart rate, respiration and gastrointestinal system, We found that there were no significant changes in body temperature, locomotors activity, stereotyped behaviors, sleeping time, and convulsion. In other studies, writhing reaction, normal body temperature, there did not appear to be any changes. The large intestine movement and electrical field stimulation-induced contraction was not changes by its EXT. In addition, the influences on blood pressure, heart rates, and respiration by QGC EXT were not found. These results indicate that QGC EXT may be very safe as a new drug, since its LD(50) was very high over 5 g/kg and any side effects were not found.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...